Form 8-K - Current report:
SEC Accession No. 0001683168-25-004766
Filing Date
2025-06-26
Accepted
2025-06-26 08:11:41
Documents
15
Period of Report
2025-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT actuate_8k.htm   iXBRL 8-K 46017
2 FORM OF WARRANT actuate_ex0401.htm EX-4.1 56248
3 FORM OF SECURITIES PURCHASE AGREEMENT, DATED JUNE 25, 2025, BY AND AMONG ACTUATE actuate_ex1001.htm EX-10.1 232073
4 FORM OF REGISTRATION RIGHTS AGREEMENT DATED JUNE 25, 2025, BY AND AMONG ACTUATE actuate_ex1002.htm EX-10.2 138128
  Complete submission text file 0001683168-25-004766.txt   743036

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE actu-20250625.xsd EX-101.SCH 3105
6 XBRL LABEL FILE actu-20250625_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE actu-20250625_pre.xml EX-101.PRE 22380
17 EXTRACTED XBRL INSTANCE DOCUMENT actuate_8k_htm.xml XML 3803
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42139 | Film No.: 251075107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)